Drug profile · INN
ganciclovir product
CYMEVENE
ganciclovir product (CYMEVENE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ganciclovir product
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
ganciclovir product (CYMEVENE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN ganciclovir product
Brand CYMEVENE
Mechanism Human herpesvirus 1 DNA polymerase inhibitor
Target DNA polymerase catalytic subunit
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ganciclovir product?
ganciclovir product (CYMEVENE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for ganciclovir product?
CYMEVENE is a marketed brand name for ganciclovir product. Check FDA Drugs@FDA for the current US label holder and prescribing information.